NYSE · CIK 0000314203
MUX McEwen Inc.
Insider trading from SEC Form 4. Last filing Jun 30, 2026. Close $17.88 on Oct 9, 2026, +14% from the 52-week low and -38% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company
Price and insider trades, last year
MUXOct 9, 2026 · close 17.88
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at McEwen Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | Stephan Michael Spears VP Corporate Development sell | $181k 12,600 shares | -77% | +121% from low0% from high | |
| 39Weak | Carmen L Diges General Counsel/Corp Sec sell | $301k 21,000 shares | -45% | +121% from low0% from high | |
| 66Notable | Robert Ross McEwen Chairman and CEO sell | $717k 50,000 shares | -100% | +121% from low0% from high | |
| 46Moderate | Richard W. Brissenden director sell | $167k 11,203 shares | -71% | +129% from low0% from high | |
| 47Moderate | Jeffrey Chan VP - Finance sell | $199k 13,333 shares | -85% | +129% from low0% from high | |
| 29Weak | Carmen L Diges General Counsel/Corp Sec sell | $301k 21,000 shares | -9% | +121% from low0% from high | |
| 51Moderate | Robert Ross McEwen Chairman and CEO sell | $717k 50,000 shares | -10% | +121% from low0% from high | |
| 40Moderate | Ian J Ball director sell | $28k 2,656 shares | -100% | +60% from low-10% from high | |
| 23Weak | Nicolas Darveau-Garneau director buy | $19k 2,285 shares | - | - |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Ian J Ball director | MOption exercise Common Stock | +160 | - | - | 320 | Jun 30, 2026 |
| Jun 29, 2026 | Ian J Ball director | MOption exercise Restricted Stock Unitsderivative | -310 | $0.00 | $0 | 310 | Jun 30, 2026 |
| Mar 19, 2026 | William M Shaver Chief Operating Officer | AGrant or award Restricted Stock Unitsderivative | +4,440 | $0.00 | $0 | 4,440 | Mar 23, 2026 |
| Mar 19, 2026 | Perry Ing Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +1,890 | $0.00 | $0 | 1,890 | Mar 23, 2026 |
| Mar 19, 2026 | Michelle Makori director | AGrant or award Deferred Stock Unitsderivative | +239 | $0.00 | $0 | 239 | Mar 23, 2026 |
| Mar 19, 2026 | Carmen L Diges General Counsel/Corp Sec | AGrant or award Restricted Stock Unitsderivative | +1,140 | $0.00 | $0 | 1,140 | Mar 23, 2026 |
| Mar 19, 2026 | Nicolas Darveau-Garneau director | AGrant or award Deferred Stock Unitsderivative | +479 | $0.00 | $0 | 479 | Mar 23, 2026 |
| Mar 19, 2026 | Dalia Nadine Asterbadi director | AGrant or award Deferred Stock Unitsderivative | +479 | $0.00 | $0 | 1,790 | Mar 23, 2026 |
| Mar 19, 2026 | John Casimir Florek director | AGrant or award Deferred Stock Unitsderivative | +479 | $0.00 | $0 | 1,790 | Mar 23, 2026 |
| Mar 19, 2026 | William M Shaver Chief Operating Officer | AGrant or award Deferred Stock Unitsderivative | +479 | $0.00 | $0 | 479 | Mar 23, 2026 |
| Dec 20, 2025 | Carmen L Diges General Counsel/Corp Sec | MOption exercise Restricted Stock Unitsderivative | -3,370 | $0.00 | $0 | 3,370 | Dec 23, 2025 |
| Dec 20, 2025 | Ian J Ball director | MOption exercise Common Stock | +160 | - | - | 160 | Dec 23, 2025 |
| Dec 20, 2025 | Stephan Michael Spears VP Corporate Development | MOption exercise Restricted Stock Unitsderivative | -1,200 | $0.00 | $0 | 1,200 | Dec 23, 2025 |
| Dec 20, 2025 | Jeffrey Chan VP - Finance | MOption exercise Common Stock | +588 | - | - | 3,691 | Dec 23, 2025 |
| Dec 20, 2025 | William M Shaver Chief Operating Officer | MOption exercise Common Stock | +11,740 | - | - | 140,533 | Dec 23, 2025 |
| Dec 20, 2025 | Perry Ing Chief Financial Officer | MOption exercise Common Stock | +2,203 | - | - | 44,272 | Dec 23, 2025 |
| Dec 20, 2025 | Stephan Michael Spears VP Corporate Development | MOption exercise Restricted Stock Unitsderivative | -500 | $0.00 | $0 | 500 | Dec 23, 2025 |
| Dec 20, 2025 | Ian J Ball director | MOption exercise Restricted Stock Unitsderivative | -310 | $0.00 | $0 | 620 | Dec 23, 2025 |
| Dec 20, 2025 | Carmen L Diges General Counsel/Corp Sec | MOption exercise Restricted Stock Unitsderivative | -1,470 | $0.00 | $0 | 2,940 | Dec 23, 2025 |
| Dec 20, 2025 | Perry Ing Chief Financial Officer | MOption exercise Common Stock | +1,083 | - | - | 45,355 | Dec 23, 2025 |
| Dec 20, 2025 | Jeffrey Chan VP - Finance | MOption exercise Common Stock | +275 | - | - | 3,966 | Dec 23, 2025 |
| Dec 20, 2025 | William M Shaver Chief Operating Officer | MOption exercise Common Stock | +5,700 | - | - | 146,233 | Dec 23, 2025 |
| Dec 20, 2025 | Jeffrey Chan VP - Finance | MOption exercise Restricted Stock Unitsderivative | -1,266 | $0.00 | $0 | 1,266 | Dec 23, 2025 |
| Dec 20, 2025 | William M Shaver Chief Operating Officer | MOption exercise Common Stock | +2,100 | - | - | 148,333 | Dec 23, 2025 |
| Dec 20, 2025 | Carmen L Diges General Counsel/Corp Sec | MOption exercise Restricted Stock Unitsderivative | -1,300 | $0.00 | $0 | 1,300 | Dec 23, 2025 |
| Dec 20, 2025 | Perry Ing Chief Financial Officer | MOption exercise Common Stock | +867 | - | - | 46,222 | Dec 23, 2025 |
| Dec 20, 2025 | Carmen L Diges General Counsel/Corp Sec | MOption exercise Restricted Stock Unitsderivative | -533 | $0.00 | $0 | 533 | Dec 23, 2025 |
| Dec 20, 2025 | Perry Ing Chief Financial Officer | MOption exercise Common Stock | +372 | - | - | 46,594 | Dec 23, 2025 |
| Dec 20, 2025 | William M Shaver Chief Operating Officer | MOption exercise Common Stock | +867 | - | - | 149,200 | Dec 23, 2025 |
| Dec 20, 2025 | Jeffrey Chan VP - Finance | MOption exercise Restricted Stock Unitsderivative | -533 | $0.00 | $0 | 533 | Dec 23, 2025 |
| Dec 20, 2025 | William M Shaver Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | -11,740 | $0.00 | $0 | 11,740 | Dec 23, 2025 |
| Dec 20, 2025 | Perry Ing Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -4,740 | $0.00 | $0 | 4,740 | Dec 23, 2025 |
| Dec 20, 2025 | William M Shaver Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | -5,700 | $0.00 | $0 | 11,400 | Dec 23, 2025 |
| Dec 20, 2025 | Perry Ing Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -2,330 | $0.00 | $0 | 4,660 | Dec 23, 2025 |
| Dec 20, 2025 | William M Shaver Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | -2,100 | $0.00 | $0 | 2,100 | Dec 23, 2025 |
| Dec 20, 2025 | Perry Ing Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -1,866 | $0.00 | $0 | 1,866 | Dec 23, 2025 |
| Dec 20, 2025 | William M Shaver Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | -867 | $0.00 | $0 | 867 | Dec 23, 2025 |
| Dec 20, 2025 | Perry Ing Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -800 | $0.00 | $0 | 800 | Dec 23, 2025 |
| Sep 19, 2025 | Stephan Michael Spears VP Corporate Development | MOption exercise Common Stock | +12,600 | $1.25 | $16k | 16,414 | Nov 19, 2025 |
| Nov 10, 2025 | Stephan Michael Spears VP Corporate Development | MOption exercise Common Stock | +558 | - | - | 4,372 | Nov 19, 2025 |
| Nov 10, 2025 | Stephan Michael Spears VP Corporate Development | MOption exercise Common Stock | +232 | - | - | 4,604 | Nov 19, 2025 |
| Sep 19, 2025 | Stephan Michael Spears VP Corporate Development | SOpen-market sale Common Stock | -12,600 | $14.35 | $181k | 3,814 | Nov 19, 2025 |
| Nov 10, 2025 | Stephan Michael Spears VP Corporate Development | MOption exercise Restricted Stock Unitsderivative | -1,200 | $0.00 | $0 | 2,400 | Nov 19, 2025 |
| Sep 19, 2025 | Stephan Michael Spears VP Corporate Development | MOption exercise Stock Option (right to buy)derivative | -12,600 | $0.00 | $0 | 0 | Nov 19, 2025 |
| Nov 10, 2025 | Stephan Michael Spears VP Corporate Development | MOption exercise Restricted Stock Unitsderivative | -500 | $0.00 | $0 | 1,000 | Nov 19, 2025 |
| Nov 10, 2025 | Jeffrey Chan VP - Finance | MOption exercise Common Stock | +588 | - | - | 2,855 | Nov 12, 2025 |
| Nov 10, 2025 | Dalia Nadine Asterbadi director | AGrant or award Deferred Stock Unitsderivative | +585 | $0.00 | $0 | 1,311 | Nov 12, 2025 |
| Nov 10, 2025 | Ian J Ball director | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Nov 12, 2025 |
| Nov 10, 2025 | Carmen L Diges General Counsel/Corp Sec | MOption exercise Common Stock | +672 | - | - | 26,768 | Nov 12, 2025 |
| Nov 10, 2025 | John Casimir Florek director | AGrant or award Deferred Stock Unitsderivative | +585 | $0.00 | $0 | 1,311 | Nov 12, 2025 |
| Nov 10, 2025 | Perry Ing Chief Financial Officer | MOption exercise Common Stock | +867 | - | - | 41,697 | Nov 12, 2025 |
| Nov 10, 2025 | Stephen Douglas Kaszas director | AGrant or award Deferred Stock Unitsderivative | +585 | $0.00 | $0 | 1,311 | Nov 12, 2025 |
| Nov 10, 2025 | William M Shaver Chief Operating Officer | MOption exercise Common Stock | +2,100 | - | - | 127,926 | Nov 12, 2025 |
| Nov 10, 2025 | Ian J Ball director | AGrant or award Restricted Stock Unitsderivative | +930 | $0.00 | $0 | 930 | Nov 12, 2025 |
| Nov 10, 2025 | Jeffrey Chan VP - Finance | MOption exercise Common Stock | +248 | - | - | 3,103 | Nov 12, 2025 |
| Nov 10, 2025 | Carmen L Diges General Counsel/Corp Sec | MOption exercise Common Stock | +276 | - | - | 27,044 | Nov 12, 2025 |
| Nov 10, 2025 | Perry Ing Chief Financial Officer | MOption exercise Common Stock | +372 | - | - | 42,069 | Nov 12, 2025 |
| Nov 10, 2025 | William M Shaver Chief Operating Officer | MOption exercise Common Stock | +867 | - | - | 128,793 | Nov 12, 2025 |
| Nov 10, 2025 | Jeffrey Chan VP - Finance | MOption exercise Restricted Stock Unitsderivative | -1,268 | $0.00 | $0 | 2,532 | Nov 12, 2025 |
| Nov 10, 2025 | Perry Ing Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -1,868 | $0.00 | $0 | 3,732 | Nov 12, 2025 |
| Nov 10, 2025 | William M Shaver Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | -2,100 | $0.00 | $0 | 4,200 | Nov 12, 2025 |
| Nov 10, 2025 | Jeffrey Chan VP - Finance | MOption exercise Restricted Stock Unitsderivative | -534 | $0.00 | $0 | 1,066 | Nov 12, 2025 |
| Nov 10, 2025 | Perry Ing Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -800 | $0.00 | $0 | 1,600 | Nov 12, 2025 |
| Nov 10, 2025 | William M Shaver Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | -867 | $0.00 | $0 | 1,733 | Nov 12, 2025 |
| Nov 10, 2025 | Carmen L Diges General Counsel/Corp Sec | MOption exercise Restricted Stock Unitsderivative | -1,300 | $0.00 | $0 | 2,600 | Nov 12, 2025 |
| Nov 10, 2025 | Perry Ing Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +6,990 | $0.00 | $0 | 6,990 | Nov 12, 2025 |
| Nov 10, 2025 | William M Shaver Chief Operating Officer | AGrant or award Restricted Stock Unitsderivative | +17,100 | $0.00 | $0 | 17,100 | Nov 12, 2025 |
| Nov 10, 2025 | Carmen L Diges General Counsel/Corp Sec | MOption exercise Restricted Stock Unitsderivative | -534 | $0.00 | $0 | 1,066 | Nov 12, 2025 |
| Nov 10, 2025 | Carmen L Diges General Counsel/Corp Sec | AGrant or award Restricted Stock Unitsderivative | +4,410 | $0.00 | $0 | 4,410 | Nov 12, 2025 |
| Sep 19, 2025 | Carmen L Diges General Counsel/Corp Sec | MOption exercise Common Stock | +21,000 | $1.25 | $26k | 47,096 | Sep 29, 2025 |
| Sep 19, 2025 | Robert Ross McEwen Chairman and CEO | MOption exercise Common Stock | +50,000 | $1.25 | $63k | 50,000 | Sep 29, 2025 |
| Sep 19, 2025 | Carmen L Diges General Counsel/Corp Sec | SOpen-market sale Common Stock | -21,000 | $14.34 | $301k | 26,096 | Sep 29, 2025 |
| Sep 19, 2025 | Robert Ross McEwen Chairman and CEO | SOpen-market sale Common Stock | -50,000 | $14.35 | $717k | 0 | Sep 29, 2025 |
| Sep 19, 2025 | Carmen L Diges General Counsel/Corp Sec | MOption exercise Stock Option (right to buy)derivative | -21,000 | $0.00 | $0 | 0 | Sep 29, 2025 |
| Sep 19, 2025 | Robert Ross McEwen Chairman and CEO | MOption exercise Stock Option (right to buy)derivative | -50,000 | $0.00 | $0 | 0 | Sep 29, 2025 |
| Sep 22, 2025 | Richard W. Brissenden director | MOption exercise Common Stock | +7,500 | $1.25 | $9,375 | 15,833 | Sep 24, 2025 |
| Sep 22, 2025 | Jeffrey Chan VP - Finance | MOption exercise Common Stock | +13,333 | $7.10 | $95k | 15,600 | Sep 24, 2025 |
| Sep 22, 2025 | Richard W. Brissenden director | SOpen-market sale Common Stock | -6,428 | $14.89 | $96k | 9,405 | Sep 24, 2025 |
| Sep 22, 2025 | Jeffrey Chan VP - Finance | SOpen-market sale Common Stock | -13,333 | $14.89 | $199k | 2,267 | Sep 24, 2025 |
| Sep 22, 2025 | Richard W. Brissenden director | MOption exercise Common Stock | +8,334 | $7.10 | $59k | 17,739 | Sep 24, 2025 |
| Sep 22, 2025 | Jeffrey Chan VP - Finance | MOption exercise Stock Option (right to buy)derivative | -13,333 | $0.00 | $0 | 6,667 | Sep 24, 2025 |
| Sep 22, 2025 | Richard W. Brissenden director | SOpen-market sale Common Stock | -4,775 | $14.88 | $71k | 12,964 | Sep 24, 2025 |
| Sep 22, 2025 | Richard W. Brissenden director | MOption exercise Stock Option (right to buy)derivative | -7,500 | $0.00 | $0 | 0 | Sep 24, 2025 |
| Sep 22, 2025 | Richard W. Brissenden director | MOption exercise Stock Option (right to buy)derivative | -8,334 | $0.00 | $0 | 8,333 | Sep 24, 2025 |
| Sep 19, 2025 | Carmen L Diges General Counsel/Corp Sec | MOption exercise Common Stock | +210,000 | $1.25 | $263k | 236,096 | Sep 23, 2025 |
| Sep 19, 2025 | Robert Ross McEwen Chairman and CEO | MOption exercise Common Stock | +500,000 | $1.25 | $625k | 500,000 | Sep 23, 2025 |
| May 6, 2025 | Robert Ross McEwen Chairman and CEO | AGrant or award Common Stockindirect: By corporation | +53,160 | $7.52 | $400k | 8,236,647 | Sep 23, 2025 |
| Sep 19, 2025 | Carmen L Diges General Counsel/Corp Sec | SOpen-market sale Common Stock | -21,000 | $14.34 | $301k | 215,096 | Sep 23, 2025 |
| Sep 19, 2025 | Robert Ross McEwen Chairman and CEO | SOpen-market sale Common Stock | -50,000 | $14.35 | $717k | 450,000 | Sep 23, 2025 |
| Sep 19, 2025 | Carmen L Diges General Counsel/Corp Sec | MOption exercise Stock Option (right to buy)derivative | -210,000 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Sep 19, 2025 | Robert Ross McEwen Chairman and CEO | MOption exercise Stock Option (right to buy)derivative | -500,000 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Sep 8, 2025 | Dalia Nadine Asterbadi director | AGrant or award Deferred Stock Unitsderivative | +726 | $0.00 | $0 | 726 | Sep 10, 2025 |
| Sep 8, 2025 | Jeffrey Chan VP - Finance | AGrant or award Restricted Stock Unitsderivative | +1,600 | $0.00 | $0 | 1,600 | Sep 10, 2025 |
| Sep 8, 2025 | Carmen L Diges General Counsel/Corp Sec | AGrant or award Restricted Stock Unitsderivative | +1,600 | $0.00 | $0 | 1,600 | Sep 10, 2025 |
| Sep 8, 2025 | John Casimir Florek director | AGrant or award Deferred Stock Unitsderivative | +726 | $0.00 | $0 | 726 | Sep 10, 2025 |
| Sep 8, 2025 | Perry Ing Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +2,400 | $0.00 | $0 | 2,400 | Sep 10, 2025 |
| Sep 8, 2025 | Stephen Douglas Kaszas director | AGrant or award Deferred Stock Unitsderivative | +726 | $0.00 | $0 | 726 | Sep 10, 2025 |
| Sep 8, 2025 | Stephan Michael Spears VP Corporate Development | AGrant or award Restricted Stock Unitsderivative | +1,500 | $0.00 | $0 | 1,500 | Sep 10, 2025 |
| Sep 8, 2025 | William M Shaver Chief Operating Officer | AGrant or award Restricted Stock Unitsderivative | +2,600 | $0.00 | $0 | 2,600 | Sep 10, 2025 |
| Aug 12, 2025 | Ian J Ball director | SOpen-market sale Common Stockindirect: By Canadian RRSP Account | -2,656 | $10.49 | $28k | 0 | Aug 14, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Dalia Nadine Asterbadidirector
- Ian J Balldirector
- Richard W. Brissendendirector
- Jeffrey ChanVP - Finance
- Nicolas Darveau-Garneaudirector
- Carmen L DigesGeneral Counsel/Corp Sec
- John Casimir Florekdirector
- Perry IngChief Financial Officer
- Stephen Douglas Kaszasdirector
- Michelle Makoridirector
- Robert Ross McEwenChairman and CEO
- William M ShaverChief Operating Officer
- Stephan Michael SpearsVP Corporate Development
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.